October 5, 2016
Kibion AB has been acquired by French company Laboratory Mayoly Spindler.
Mayoly Spindler, the independent French benchmark laboratory in gastroenterology and dermo-cosmetics, is continuing its international development with the acquisition of the young Swedish company Kibion. Mayoly Spindler has thereby become the leading company in the market or Urea Breath Tests used to diagnose the presence of Helicobacter pylori and control its eradication.
Mathieu Duroselle, CEO
Phone: +33 (0)1 34 80 40 82
Mobile: +33 (0)7 61 41 95 55
Kibion is a diagnostic company and a world-leading supplier of breath tests and analytical instruments for diagnosing the gastric ulcer bacterium Helicobacter pylori. The products Kibion® Dynamic, Heliprobe®System and Diabact®UBT are sold in more than 60 countries with the Middle East and the EU being the largest markets. Kibion is headquartered in Uppsala, Sweden, with a subsidiary, Kibion GmbH, in Bremen, Germany. www.kibion.com.
About Mayoly Spindler
Mayoly Spindler, a French, privately-owned pharmaceutical company, was founded in 1929 and developed steadily with effective and well known medicines in several disease areas such as gastroenterology, rheumatology, ENT, general medicine and public health. The company is also active in dermo-cosmetics with the Charlieu and Topicrem brands.
Equipped with its own manufacturing facilities, Mayoly Spindler has a solid grip on its own industrial development.